Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

A Scoping Review on the Expected Role of Community Pharmacists in the Era of COVID-19 Pandemic Crisis Across OECD Countries

OECD 회원국에서 COVID-19 팬더믹 위기시대 지역약사의 확장된 역할에 대한 주제범위 문헌고찰

  • Received : 2022.08.26
  • Accepted : 2022.12.12
  • Published : 2022.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: Community pharmacists are frontline health care providers, but have been considered as underutilized professionals on a daily basis. The purpose of this scoping review was to identify information about the impact of the COVID-19 pandemic on community pharmacy services and to evaluate new services that could be applicable. Methods: We searched MEDLINE and EMBASE for studies published up to January 10, 2020. Search terms consisted of keywords relevant to this review, including "COVID-19", "community pharmacy", and "community pharmacist". This review targeted studies of pharmacist services provided by community pharmacies in OECD member countries during the COVID-19 pandemic period. Results: Twenty-seven studies were included in this review. Changes in community pharmacist services due to the COVID-19 pandemic were broadly classified into four categories. First, as the face-to-face services became challenging, various non-face-to-face services were being tried. Second, community pharmacists directly participated in the services to prevent the spread of COVID-19. Third, community pharmacists made efforts to support continuity of care for patients who experienced difficulties due to the reduced professional care as health and medical resources are concentrated in response to COVID-19. Fourth, community pharmacist services were emerging, targeting patients suffering from greater health inequality during the pandemic. Patients expressed high demand and satisfaction for the service of the community pharmacist, and pharmacists reported self-efficacy and professional pride. Conclusion: This study demonstrated that in the era of the COVID-19 pandemic, various community pharmacist services have been tried and received positive evaluations from patients in several OECD countries.

Keywords

Acknowledgement

본 연구는 2021년 영남대학교 학술연구조성비의 지원을 받아 수행되었다(grant no. 221A380126).

References

  1. World Health Organization. Declaration of Astana. Astana, Kazakhstan: World Health Organization, 2018. Available from https://www.who.int/docs/default-source/primary-health/declaration/gcphc-declaration.pdf. Accessed July 27, 2022.
  2. International Pharmaceutical Federation. FIP Community Pharmacy Section. Vision 2020-2025: Pharmacists at the heart of our communities. 2020. Available from www.fip.org/files/CPS_vision_FINAL.pdf. Accessed July 27, 2022.
  3. Iacobucci G. Covid-19: all non-urgent elective surgery is suspended for at least three months in England. BMJ 2020;368:m1106. https://doi.org/10.1136/bmj.m1106
  4. Rimmer A. Covid-19: GPs can stop health checks for over 75s and routine medicine reviews. BMJ 2020;368:m1157. https://doi.org/10.1136/bmj.m1157
  5. Ahn S, Kim S, Koh K. Associations of the COVID-19 pandemic with older individuals' healthcare utilization and self-reported health status: a longitudinal analysis from Singapore. BMC Health Serv Res 2022;22(1):66. https://doi.org/10.1186/s12913-021-07446-5
  6. Birkmeyer JD, Barnato A, Birkmeyer N, Bessler R, Skinner J. The impact of the COVID-19 pandemic on hospital admissions in the United States. Health Aff 2020;39(11):2010-7. https://doi.org/10.1377/hlthaff.2020.00980
  7. Lantelme P, Couray Targe S, Metral P, et al. Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic. Arch Cardiovasc Dis 2020;113(6-7):443-7. https://doi.org/10.1016/j.acvd.2020.06.001
  8. Mehrotra A, Chernew ME, Linetsky D, Hatch H, Cutler DA, Schneider EC. The Impact of COVID-19 on Outpatient Visits in 2020: Visits Remained Stable, Despite a Late Surge in Cases. New York: The Commonwealth Fund, 2021. Available from https://www.commonwealthfund.org/publications/2021/feb/impact-covid19-outpatient-visits-2020-visits-stable-despite-late-surge. Accessed July 29, 2022.
  9. Dopfer C, Wetzke M, Zychlinsky Scharff A, et al. COVID-19 related reduction in pediatric emergency healthcare utilization - a concerning trend. BMC Pediatr 2020;20(1):427. https://doi.org/10.1186/s12887-020-02303-6
  10. Lam W, Mey A, King MA, Woods P. The nature of conflict in community pharmacy - A pilot study of pharmacists' experiences during the COVID-19 pandemic. Res Social Adm Pharm 2022;18(7):3164-73. https://doi.org/10.1016/j.sapharm.2021.09.002
  11. Kone A, Horter L, Rose C, et al. The impact of traumatic experiences, coping mechanisms, and workplace benefits on the mental health of U.S. public health workers during the COVID-19 pandemic. Ann Epidemiol 2022;74:66-74. https://doi.org/10.1016/j.annepidem.2022.07.001
  12. Sheehan KA, Schulz-Quach C, Ruttan LA, et al. "Don't just study our distress, do something": Implementing and evaluating a modified stepped-care model for health care worker mental health during the COVID-19 pandemic. Can J Psychiatry 2023;68(1):43-53. https://doi.org/10.1177/07067437221111372
  13. Sayarshad HR. Personal protective equipment market coordination using subsidy. Sustain Cities Soc 2022;85:104044. https://doi.org/10.1016/j.scs.2022.104044
  14. Jo J. <'Corona 19' Super Emergency> The app saying 'Masks in stock,' but actually "None" at pharmacy. Munhwa Ilbo, 2020. Available from https://news.v.daum.net/v/20200311120049173. Accessed August 18, 2022.
  15. Park M, Shin Y. "What should I do? All cold medicine is out of stock" Pharmacies are at war. Kookmin Ilbo, 2022. Available from https://news.v.daum.net/v/20220321000401247. Accessed August 18, 2022.
  16. Cadogan CA, Hughes CM. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis. Res Social Adm Pharm 2021;17(1):2032-5. https://doi.org/10.1016/j.sapharm.2020.03.015
  17. El Hadidi S, Sabra K. What we learnt after looking back at the community pharmacists' experiences worldwide in COVID-19 pandemic. J Pharm Pract 2021:8971900211036093.
  18. Jeong M. [COVID-19] KPA, supply the same quantity and uniform price of masks to pharmacies nationwide. Financial News, 2020. Available from https://news.v.daum.net/v/20200303060029946. Accessed August 18, 2022.
  19. Oh NS, Yoo W-K, Lee I-H. Perception on necessity to introduce public out-of-hours pharmacies and operation plan: A Gyeongsangbukdo case. Korean J Clin Pharm 2022;32(2):93-105. https://doi.org/10.24304/kjcp.2022.32.2.93
  20. Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 2018;169(7):467-73. https://doi.org/10.7326/m18-0850
  21. Amariles P, Ledezma-Morales M, Salazar-Ospina A, Hincapie-Garcia JA. How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal. Res Social Adm Pharm 2021;17(1):1988-9. https://doi.org/10.1016/j.sapharm.2020.03.007
  22. Baratta F, Ciccolella M, Brusa P. The relationship between customers and community pharmacies during the covid-19 (Sarscov-2) pandemic: A survey from Italy. Int J Environ Res Public health 2021;18(18):9582. https://doi.org/10.3390/ijerph18189582
  23. Bourdin A, Dotta-Celio J, Niquille A, Berger J. Response to the first wave of the COVID-19 pandemic in the community pharmacy of a University Center for Primary Care and Public Health. Res Social Adm Pharm 2022;18(4):2706-10. https://doi.org/10.1016/j.sapharm.2021.06.010
  24. Cerbin-Koczorowska M, Waszyk-Nowaczyk M. Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland. Int J Environ Res Public health 2020;17(18):6659. https://doi.org/10.3390/ijerph17186659
  25. Crowley D, Delargy I. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report. Harm Reduct J 2020;17(1):49. https://doi.org/10.1186/s12954-020-00394-z
  26. Daskalakis G, Cid A, Grindrod K, Beazely MA. Investigating community pharmacy take home naloxone dispensing during COVID-19: The impact of one public health crisis on another. Pharmacy 2021;9(3):129. https://doi.org/10.3390/pharmacy9030129
  27. Giua C, Paoletti G, Minerba L, et al. Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists. Int J Clin Pharm 2021;43(3):708-15. https://doi.org/10.1007/s11096-020-01228-5
  28. Gregory PAM, Austin Z. COVID-19: How did community pharmacies get through the first wave? Can Pharm J (Ott) 2020;153(5):243-51. https://doi.org/10.1177/1715163520945741
  29. Imlach F, McKinlay E, Kennedy J, et al. E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand. BMC Fam Pract 2021;22(1):140. https://doi.org/10.1186/s12875-021-01490-0
  30. Klepser NS, Klepser DG, Adams JL, Adams AJ, Klepser ME. Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities. Res Social Adm Pharm 2021;17(9):1574-8. https://doi.org/10.1016/j.sapharm.2020.12.003
  31. Koster ES, Philbert D, Bouvy ML. Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Res Social Adm Pharm 2021;17(1):2002-4. https://doi.org/10.1016/j.sapharm.2020.07.001
  32. Lim RH, Shalhoub R, Sridharan BK. The experiences of the community pharmacy team in supporting people with dementia and family carers with medication management during the COVID-19 pandemic. Res Social Adm Pharm 2021;17(1):1825-31. https://doi.org/10.1016/j.sapharm.2020.10.005
  33. Lin CH, Lin YW, Wang JY, Lin MH. The pharmaceutical practice of mask distribution by pharmacists in Taiwan's community pharmacies under the Mask Real-Name System, in response to the COVID-19 outbreak. Cost Eff Resour Alloc 2020;18:45. https://doi.org/10.1186/s12962-020-00239-3
  34. Lin YW, Lin CH, Lin MH. Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan. Cost Eff Resour Alloc 2021;19(1):76. https://doi.org/10.1186/s12962-021-00331-2
  35. Lubi K, Sepp K, Rass H, Roostar K, Volmer D. A qualitative study of the challenges in rearranging community pharmacy service provision during the COVID-19 public health emergency: The prism of social practice theory. Public Health Pract (Oxf) 2021;2:100212. https://doi.org/10.1016/j.puhip.2021.100212
  36. Mamiya KT, Yoshida A. Changes in Japanese pharmacists' recognition of their role in community public health before and after the spread of COVID-19. Pharmacy (Basel) 2021;9(3):154. https://doi.org/10.3390/pharmacy9030154
  37. Manouchehri M, Bhamra SK, Fernandez-Alfonso MS, Gil-Ortega M. The real impact of COVID-19 on community pharmacy professionals as part of the primary health care frontier workforce in Spain. J Pharm Pharmacogn Res 2021;9(6):878-91. https://doi.org/10.56499/jppres21.1081_9.6.878
  38. Molas ME, Knobel H, Ferrandez O, et al. Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment. Rev Esp Quimioter 2022;35(1):71-5. https://doi.org/10.37201/req/055.2021
  39. Okuyan B, Bektay MY, Kingir ZB, Save D, Sancar M. Community pharmacy cognitive services during the COVID-19 pandemic: A descriptive study of practices, precautions taken, perceived enablers and barriers and burnout. Int J Clin Pract 2021;75(12):e14834.
  40. Patel J, Christofferson N, Goodlet KJ. Pharmacist-provided SARS-CoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic: Results of a patient perception survey. J Am Pharm Assoc 2022;62(1):187-93. https://doi.org/10.1016/j.japh.2021.08.015
  41. Pelaez Bejarano A, Villar Santos P, Robustillo-Cortes MLA, Sanchez Gomez E, Santos Rubio MD. Implementation of a novel home delivery service during pandemic. Eur J Hosp Pharm 2021;28(Suppl 2):e120-e123. https://doi.org/10.1136/ejhpharm-2020-002500
  42. Stampfli D, Martinez-De la Torre A, Simi E, Du Pasquier S, Berger J, Burden AM. Community pharmacist-administered covid-19 vaccinations: A pilot customer survey on satisfaction and motivation to get vaccinated. Vaccines (Basel) 2021;9(11):1320. https://doi.org/10.3390/vaccines9111320
  43. Stoa MK, Frail CK, Farley JF, Pestka DL, Blanchard CM. Adaptations made to delivery of comprehensive medication management in the community pharmacy setting during COVID-19. Explor Res Clin Soc Pharm 2021;4:100089.
  44. Toth JM, Rosenthal M, Sharma M, Barnard M. Caregivers' Perspectives of Pharmacist Intervention in Children's Antibiotic Prescriptions for Upper Respiratory Tract Infections. J Pharm Pract 2021:8971900211033459.
  45. Zaidi STR, Hasan SS. Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey. Res Social Adm Pharm 2021;17(1):1832-7. https://doi.org/10.1016/j.sapharm.2020.07.006
  46. Zimmermann A, Placzek J, Wrzosek N, Owczarek A. Assessment of pharmacists prescribing practices in Poland-A descriptive study. Healthcare (Basel) 2021;9(11):1505.
  47. Zozaya N, Gonzalez-Dominguez A, Calvente N, et al. Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: A pilot experience in times of COVID-19 in Spain. Glob Reg Health Technol Assess 2021;8(1):8-13.
  48. Jordan D, Guiu-Segura JM, Sousa-Pinto G, Wang LN. How COVID-19 has impacted the role of pharmacists around the world. Farm Hosp 2021;45(2):89-95.
  49. Rezahi S, Mathers A, Patel P, Tilli T, Dolovich L. Telehealth in community pharmacy: A new "place" for the appointment-based model given COVID-19 and the future of health care. Can Pharm J (Ott) 2021;154(6):363-7. https://doi.org/10.1177/17151635211014922
  50. Littauer SL, Dixon DL, Mishra VK, Sisson EM, Salgado TM. Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review. Pharm Pract (Granada) 2017;15(4):1134. https://doi.org/10.18549/PharmPract.2017.04.1134
  51. Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review. Res Social Adm Pharm 2018;14(8):707-17. https://doi.org/10.1016/j.sapharm.2017.10.011
  52. Henderson C, Knapp M, Fernandez JL, et al. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ 2013;346:f1035. https://doi.org/10.1136/bmj.f1035
  53. Lee J. Investigation review of Ministry of Health and Welfare, 'special pharmacy for drug delivery'. MedicalTimes, 2022. Available from https://www.medicaltimes.com/Main/News/NewsView.html?ID=1148541&ref=daum. Accessed August 18, 2022.
  54. Kang H. "Discussion of institutionalization for non face-to-face service, issues of electronic prescription and drug delivery". DailyPharm, 2022. Available from http://www.dailypharm.com/Users/News/NewsView.html?ID=288550&REFERER=DM. Accessed August 18, 2022.
  55. Smith AC, Thomas E, Snoswell CL, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare 2020;26(5):309-13. https://doi.org/10.1177/1357633X20916567
  56. Maidment I, Young E, MacPhee M, et al. Rapid realist review of the role of community pharmacy in the public health response to COVID-19. BMJ open 2021;11(6):e050043. https://doi.org/10.1136/bmjopen-2021-050043
  57. Hess K, Bach A, Won K, Seed SM. Community pharmacists roles during the COVID-19 pandemic. J Pharm Pract 2022;35(3):469-76. https://doi.org/10.1177/0897190020980626
  58. Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health 2020;74(11):964-8.
  59. Cohen MA, Tavares J. Who are the most at-risk older adults in the COVID-19 era? It's not just those in nursing homes. J Aging Soc Policy 2020;32(4-5):380-6. https://doi.org/10.1080/08959420.2020.1764310
  60. Beland D, Marier P. COVID-19 and long-term care policy for older people in Canada. J Aging Soc Policy 2020;32(4-5):358-64. https://doi.org/10.1080/08959420.2020.1764319
  61. Shinan-Altman S, Levkovich I. Healthcare utilization among breast cancer patients during the COVID-19 outbreak. Palliat Support Care 2020;18(4):385-91. https://doi.org/10.1017/S1478951520000516
  62. Kirby A, Drummond FJ, Lawlor A, Murphy A. Counting the social, psychological, and economic costs of COVID-19 for cancer patients. Support Care Cancer 2022;30(11):8705-31. https://doi.org/10.1007/s00520-022-07178-0
  63. Latif A, Faull C, Waring J, et al. Managing medicines at the end of life: a position paper for health policy and practice. J Health Organ Manag 2021;35(9):368-77. https://doi.org/10.1108/JHOM-11-2020-0440
  64. Park H. Seoul Pharmaceutical Association opens a forum for infectious diseases and the role of pharmacists and pharmacies. Kyunghyang Shinmun, 2022. Available from https://news.v. daum.net/v/20220509143132209. Accessed August 18, 2022.
  65. Park K, Byeon J, Yang Y, Cho H. Healthcare utilisation for elderly people at the onset of the COVID-19 pandemic in South Korea. BMC Geriatr 2022;22(1):395. https://doi.org/10.1186/s12877-022-03085-5
  66. Wasilewski MB, Szigeti Z, Sheppard CL, et al. Infection prevention and control across the continuum of COVID-19 care: A qualitative study of patients', caregivers' and providers' experiences. Health Expect 2022;25(5):2431-9. https://doi.org/10.1111/hex.13558
  67. Austin Z, Gregory P. Resilience in the time of pandemic: The experience of community pharmacists during COVID-19. Res Social Adm Pharm 2021;17(1):1867-75. https://doi.org/10.1016/j.sapharm.2020.05.027